Literature DB >> 16769953

Mortality of stroke patients treated with thrombolysis: analysis of nationwide inpatient sample.

Richard Dubinsky1, Sue-Min Lai.   

Abstract

The authors performed a retrospective cohort comparison using the Nationwide Inpatient Sample for 1999 through 2002 of acute ischemic stroke admissions. Mortality was compared based on the use of thrombolysis. Hospital mortality was significantly greater for the thrombolysis cohort (10.1% vs 5.8%) as was the rate of secondary intracranial hemorrhage (4.2% vs 0.4%). US community experience in the use of thrombolysis has higher rates of complications and mortality than in controlled clinical trials.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16769953     DOI: 10.1212/01.wnl.0000218306.35681.38

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  10 in total

1.  A theoretical and experimental evaluation of the microangiographic fluoroscope: A high-resolution region-of-interest x-ray imager.

Authors:  Amit Jain; D R Bednarek; Ciprian Ionita; S Rudin
Journal:  Med Phys       Date:  2011-07       Impact factor: 4.071

2.  An insult-inducible vector system activated by hypoxia and oxidative stress for neuronal gene therapy.

Authors:  Michelle Y Cheng; I-Ping Lee; Michael Jin; Guohua Sun; Heng Zhao; Gary K Steinberg; Robert M Sapolsky
Journal:  Transl Stroke Res       Date:  2011-03-01       Impact factor: 6.829

3.  Thrombolysis is an Independent Risk Factor for Poor Outcome After Carotid Revascularization.

Authors:  Ananth K Vellimana; Chad W Washington; Chester K Yarbrough; Thomas K Pilgram; Brian L Hoh; Colin P Derdeyn; Gregory J Zipfel
Journal:  Neurosurgery       Date:  2018-11-01       Impact factor: 4.654

Review 4.  Central nervous system agents for ischemic stroke: neuroprotection mechanisms.

Authors:  Rachna S Pandya; Lijuan Mao; Hua Zhou; Shuanhu Zhou; Jiang Zeng; A John Popp; Xin Wang
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2011-06-01

5.  National use of thrombolysis with alteplase for acute ischaemic stroke via telemedicine in Denmark: a model of budgetary impact and cost effectiveness.

Authors:  Lars Ehlers; Wilhelmina Maria Müskens; Lotte Groth Jensen; Mette Kjølby; Grethe Andersen
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

6.  ICD9 codes cannot reliably identify hemorrhagic transformation of ischemic stroke.

Authors:  Michael T Mullen; Charles J Moomaw; Kathleen Alwell; Jane C Khoury; Brett M Kissela; Daniel Woo; Matthew L Flaherty; Pooja Khatri; Opeolu Adeoye; Simona Ferioli; Dawn Kleindorfer
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-07-02

7.  Comparison of short-term outcomes of thrombolysis for in-hospital stroke and out-of-hospital stroke in United States.

Authors:  Yogesh Moradiya; Steven R Levine
Journal:  Stroke       Date:  2013-04-30       Impact factor: 7.914

8.  Thrombolytic utilization for ischemic stroke in US hospitals with neurology residency program.

Authors:  Yogesh Moradiya; Howard Crystal; Helen Valsamis; Steven R Levine
Journal:  Neurology       Date:  2013-11-01       Impact factor: 9.910

9.  Gene-drug interaction in stroke.

Authors:  Serena Amici; Maurizio Paciaroni; Giancarlo Agnelli; Valeria Caso
Journal:  Stroke Res Treat       Date:  2011-11-10

10.  Analysis of Cynandione A's Anti-Ischemic Stroke Effects from Pathways and Protein-Protein Interactome.

Authors:  Haiyang Fang; Rongcai Yue; Yang Ga; Yi Zhang; Lei Shan; Jing Zhao
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.